Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
27,643,703
-
Share change
-
+1,053,225
-
Total reported value
-
$150,101,213
-
Price per share
-
$5.43
-
Number of holders
-
73
-
Value change
-
+$4,146,701
-
Number of buys
-
34
-
Number of sells
-
37
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2021
As of 30 Jun 2021,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,643,703 shares.
The largest 10 holders included
Bellevue Group AG, BlackRock Inc., Logos Global Management LP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, Prosight Management, LP, MILLENNIUM MANAGEMENT LLC, and DEUTSCHE BANK AG\.
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.